Argonaut Manufacturing Services Selected to Manufacture siRNA Medicines for Potential Prion Disease Trial Argonaut to support manufacturing needs of an siRNA therapeutic for a potential
Long-standing partnership strengthens as both companies target growth in IVD sector Carlsbad, CA, Jan 28, 2025 — Argonaut Manufacturing Services (“Argonaut”), a leading contract
Biopharma gains a seamless transition from drug discovery through drug product manufacturing San Diego, CA, June 20, 2024 – Abzena, the leading end-to-end integrated contract
Argonaut Manufacturing Services Expands Aseptic Pharmaceutical Fill / Finish Capabilities with $45 Million Equity Investment from NewVale Capital and Telegraph Hill Partners Investment strengthens Argonaut’s
KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions Alliance
Argonaut Manufacturing Services Expands Manufacturing Partnerships with Rare Disease Organizations CARLSBAD, CA March 08, 2023— Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO)
Expanding drug product fill/finish capabilities Carlsbad, CA, 10th January 2023 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the life sciences, molecular
Launch of LyoDots – World’s Smallest Lyophilized Reagents Carlsbad, CA, 7/26/22 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the biopharma, life
Simplify Molecular Assays with BioFuse Sample Prep Device Carlsbad, CA, 7/25/22 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the biopharma, life
Argonaut to support n-Lorem’s expanding need for manufacturing of ASO therapeutics for nano-rare patients SAN DIEGO, Calif., Feb. 2, 2022, Argonaut Manufacturing Services a leading